Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer

Hoyos, V; Vasileiou, S; Kuvalekar, M; Watanabe, A; Tzannou, I; Velazquez, Y; French-Kim, M; Leung, W; Lulla, S; Robertson, C; Foreman, C; Wang, T; Bulsara, S; Lapteva, N; Grilley, B; Ellis, M; Osborne, CK; Coscio, A; Nangia, J; Heslop, HE; Rooney, CM; Vera, JF; Lulla, P; Rimawi, M; Leen, AM

Hoyos, V (通讯作者)，Texas Childrens Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.;Hoyos, V (通讯作者)，Houston Methodist Hosp, Houston, TX 77030 USA.;Hoyos, V (通讯作者)，Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, 1102 Bates Ave,Feigin Ctr 17th Floor, Houston, TX 77030 USA.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022; 14 ():

Abstract

Purpose: Adoptively transferred, ex vivo expanded multi-antigen-targeted T cells (multiTAA-T) represent a new, potentially effective, and nontoxic the......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索